Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases

BACKGROUND: We previously demonstrated the safety of stereotactic body radiotherapy followed by pembrolizumab (SBRT+P) in patients with advanced solid tumors. This phase I clinical trial was expanded to study the safety of partial tumor irradiation (partial-Rx). We assessed irradiated local failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Korpics, Mark C., Onderdonk, Benjamin E., Dadey, Rebekah E., Hara, Jared H., Karapetyan, Lilit, Zha, Yuanyuan, Karrison, Theodore G., Olson, Adam C., Fleming, Gini F., Weichselbaum, Ralph R., Bao, Riyue, Chmura, Steven J., Luke, Jason J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178837/
https://www.ncbi.nlm.nih.gov/pubmed/37183819
http://dx.doi.org/10.1172/JCI162260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178837/
https://www.ncbi.nlm.nih.gov/pubmed/37183819
http://dx.doi.org/10.1172/JCI162260

Ejemplares similares